/
/
/

Indrayani Biotech Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Sep 2012Jun 2012Mar 2012Dec 2011Sep 2011Jun 2011Mar 2011Dec 2010Sep 2010
₹73 Cr₹35 Cr₹36 Cr₹29 Cr₹51 Cr₹17 Cr₹31 Cr₹32 Cr₹44 Cr₹39 Cr₹40 Cr₹42 Cr₹49 Cr₹46 Cr₹42 Cr₹26 Cr₹17 Cr₹15 Cr₹15 Cr₹14 Cr₹7 Cr₹6 Cr₹5 Cr₹3 Cr₹14 Cr₹34 Cr₹22 Cr₹12 Cr₹12 Cr₹17 Cr₹14 Cr₹6 Cr₹9 Cr₹16 Cr
₹2 Cr₹83 L₹2 Cr₹2 Cr₹3 Cr₹40,000₹30 L₹4 L₹1 Cr₹8 L₹9 L₹90,000₹2 Cr₹8 L₹2 Cr₹39 L₹50,000₹15 L₹4 L₹3 L₹15 L₹1 L₹3 L₹7 L₹1 L₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹74 Cr₹36 Cr₹38 Cr₹31 Cr₹53 Cr₹17 Cr₹31 Cr₹32 Cr₹45 Cr₹39 Cr₹41 Cr₹42 Cr₹51 Cr₹46 Cr₹44 Cr₹26 Cr₹17 Cr₹15 Cr₹15 Cr₹14 Cr₹7 Cr₹6 Cr₹5 Cr₹3 Cr₹14 Cr₹34 Cr₹22 Cr₹12 Cr₹12 Cr₹17 Cr₹14 Cr₹6 Cr₹9 Cr₹16 Cr
₹70 Cr₹33 Cr₹35 Cr₹30 Cr₹55 Cr₹16 Cr₹29 Cr₹28 Cr₹35 Cr₹37 Cr₹34 Cr₹41 Cr₹47 Cr₹41 Cr₹37 Cr₹23 Cr₹15 Cr₹14 Cr₹13 Cr₹13 Cr₹8 Cr₹5 Cr₹4 Cr₹9 Cr₹14 Cr₹34 Cr₹21 Cr₹13 Cr₹13 Cr₹17 Cr₹14 Cr₹7 Cr₹8 Cr₹15 Cr
₹7 Cr₹4 Cr₹4 Cr₹5 Cr-₹3 Cr₹3 Cr₹5 Cr₹4 Cr₹11 Cr₹4 Cr₹7 Cr₹3 Cr₹5 Cr₹6 Cr₹7 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr-₹42 L₹93 L₹64 L-₹5 Cr₹91 L₹17 L₹28 L-₹34 L-₹34 L-₹3 L₹33 L-₹4 L₹32 L₹34 L
₹6 Cr₹2 Cr₹2 Cr₹86 L₹7 Cr₹1 Cr₹1 Cr₹2 Cr₹6 Cr₹1 Cr₹93 L₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹97 L₹44 L₹59 L₹53 L₹32 L₹1 Cr₹36 L₹31 L₹29 L₹28 L₹4 L₹8 L₹12 L₹12 L₹6 L₹11 L₹13 L₹16 L₹5 L
-₹97 L₹14 L₹1 Cr₹21 L-₹8 Cr₹43 L₹1 Cr₹94 L₹5 Cr₹1 Cr₹6 Cr-₹38 L₹2 Cr₹3 Cr₹5 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹63 L-₹3 Cr-₹2 Cr₹12 L-₹5 Cr₹28 L₹4 L₹13 L-₹53 L-₹53 L-₹16 L₹15 L-₹26 L₹10 L₹22 L
₹1 Cr₹12 L₹91 L₹16 L-₹9 Cr₹35 L₹1 Cr₹85 L₹5 Cr₹1 Cr₹6 Cr-₹44 L₹1 Cr₹3 Cr₹5 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹63 L-₹3 Cr-₹2 Cr₹12 L-₹5 Cr₹28 L₹4 L₹13 L-₹53 L-₹53 L-₹16 L₹15 L-₹41 L₹6 L₹18 L

Share Price Live Stats

Open (₹)8.98
Volume (₹)9,549.00
High (₹)8.98
Upper Circuit10.53
Low (₹)8.02
Lower Circuit7.03
Prev Close8.78
52W High (₹)18.05
Price8.69
52W Low (₹)6.69

Share Market Cap & Key Ratios Overview

M.Cap (₹)68.54 Cr
Div. Yield (%)0.00
PE Ratio31.73
Debt to Equity1.99
Price to Book0.86
Book Value16.61
EPS (TTM)0.28
Face Value10.00
ROE (%)-9.25

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
GRASIM-ANSE
3MINDIA-ANSE
DCMSHRIRAM-ANSE
BILVYAPAR-TNSE
INDRANIB-XNSE
LTP
1W Low
1W High
Market cap (₹)
3328.25+39.25 (1.19%)
3236
3370
2,25,272Cr
32910.45-1590.7 (-4.61%)
32580
34020.45
36,899Cr
1022.6+0.7 (0.07%)
1010
1051
15,906Cr
4.02+0.01 (0.25%)
3.90
4.19
12Cr
8.69+0.75 (9.45%)
7.40
8.98
69Cr

Key Highlights of Indrayani Biotech Ltd’s P&L

In 2025-03-31, Indrayani Biotech Ltd reported total revenue of ₹133.35Cr, compared with ₹167.44Cr in 2024-03-31, reflecting Indrayani Biotech Ltd turnover.

Depreciation was ₹3.37Cr and finance costs were ₹11.88Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹-₹5.74Cr in 2025-03-31 as compared to ₹10.97Cr in 2024-03-31.

Net Profit (PAT) was ₹-₹1.56Cr in 2025-03-31 compared with ₹6.36Cr in 2024-03-31.

Earnings per share (EPS) were ₹-0.34 in 2025-03-31, compared with ₹1.40 in 2024-03-31.